May 2010
CMAJ: Canadian Medical Association Journal;5/18/2010, Vol. 182 Issue 8, pE344
Academic Journal
The article offers news briefs related to health. According to a report by the World Health organization, 440,000 people around the world suffered from multidrug-resistant tuberculosis and 1.8 million people died of it in 2008. Pfizer Inc. contributed 15.3 million dollars to the U.S. medical centers for conducting clinical trials in 2009. Blood services in Canada will ban donation of blood from people suffering with chronic fatigue syndrome.


Related Articles

  • Assessment of recovery status in chronic fatigue syndrome using normative data. Matthees, Alem // Quality of Life Research;Apr2015, Vol. 24 Issue 4, p905 

    Introduction: Adamowicz et al. have reviewed criteria previously employed to define recovery in chronic fatigue syndrome (CFS). They suggested such criteria have generally lacked stringency and consistency between studies and recommended future research should require 'normalization of symptoms...

  • Hidden benefits of blood donation? P.F.C. // Cortlandt Forum;8/25/96, Vol. 9 Issue 8, p117 

    Presents a response to the query on the health benefits of blood donation and explains the absence of any statistics supporting this hypothesis.

  • Development of New Anti-tuberculosis Drug Candidates. Shi, Ruiru; Sugawara, Isamu // Tohoku Journal of Experimental Medicine;Jun2010, Vol. 221 Issue 2, p97 

    Mycobacterium tuberculosis, the causative agent of tuberculosis, is a tenacious and remarkably successful pathogen that has latently infected one third of the world's population, according to the World Health Organization (WHO) statistics. It is anticipated that 10% of these infected individuals...

  • Chronic Fatigue Syndrome -- A clinically empirical approach to its definition and study. Reeves, William C.; Dieter Wagner; Rosane Nisenbaum; James F Jones; Brian Gurbaxani; Laura Solomon; Dimitris A Papanicolaou; Elizabeth R Unger; Suzanne D Vernon; Christine Heim // BMC Medicine;2005, Vol. 3, p19 

    Background: The lack of standardized criteria for defining chronic fatigue syndrome (CFS) has constrained research. The objective of this study was to apply the 1994 CFS criteria by standardized reproducible criteria. Methods: This population-based case control study enrolled 227 adults...

  • Protocol for the PACE trial: A randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with... White, Peter D.; Sharpe, Michael C.; Chalder, Trudie; DeCesare, Julia C.; Walwyn, Rebecca // BMC Neurology;2007, Vol. 7, p6 

    Background: Chronic fatigue syndrome (CFS, also called myalgic encephalomyelitis/encephalopathy or ME) is a debilitating condition with no known cause or cure. Improvement may occur with medical care and additional therapies of pacing, cognitive behavioural therapy and graded exercise therapy....

  • New centres for fatigue referral.  // GP: General Practitioner;2/2/2004, p20 

    General practitioners (GP) will be able to refer patients suffering from chronic fatigue syndrome and myalgic encephalopathy (ME) to new specialist centres from April. An£ 8.5 million project will see the creation of 12 new centres in England. The centres will provide patients with access to...

  • Strategies for Treating Latent Multiple-Drug Resistant Tuberculosis: A Decision Analysis. Holland, David P.; Sanders, Gillian D.; Hamilton, Carol D.; Stout, Jason E. // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Background: The optimal treatment for latent multiple-drug resistant tuberculosis infection remains unclear. In anticipation of future clinical trials, we modeled the expected performance of six potential regimens for treatment of latent multipledrug resistant tuberculosis. Methods: A...

  • Drug-resistant TB a continuing global public health threat.  // Nation's Health;May/Jun2010, Vol. 40 Issue 4, p13 

    The article focuses on the threat to global public health from multidrug-resistant tuberculosis (TB), a disease caused by bacteria that are resistant to at least the two most effective anti-TB drugs.

  • Health officials warn of poor tuberculosis detection. Padma, T. V. // Nature Medicine;Apr2010, Vol. 16 Issue 4, p351 

    The article reports that over 500,000 cases of multi drug resistant tuberculosis (MDR-TB) occur annually worldwide where Southeast Asia has 28 percent of the world's MDR-TB cases, according to the World Health Organization (WHO).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics